about
The molecular mechanisms that control thrombopoiesisMegakaryocytes, malignancy and bone marrow vascular nichesRole of platelets in neuroinflammation: a wide-angle perspectiveInvolvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.Pathogenesis of bone metastasis: a review.Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development.Mining to find the lipid interaction networks involved in Ovarian CancersInterleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model.Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expressionRoles of bone marrow cells in skeletal metastases: no longer bystandersPlatelet glycoprotein Ib alpha supports experimental lung metastasisIdentification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasisPlatelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.Clinical evidence for the use of aspirin in the treatment of cancer.A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway.Cancer and thrombosis: from molecular mechanisms to clinical presentations.Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patientsEvaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.New pharmacological strategies against metastatic spread.Skeletal metastasis: treatments, mouse models, and the Wnt signaling.Bone metastasis risk factors in breast cancer.HIF-mediated endothelial response during cancer progression.Adhesion receptors as therapeutic targets for circulating tumor cells.Prognostic role of elevated platelet count in patients with lung cancer: a systematic review and meta-analysis.Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation.Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions.Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation.Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells.Coagulation and metastasis--an unexpected role for von Willebrand factor.Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production.Tropomyosin isoform Tpm2.1 regulates collective and amoeboid cell migration and cell aggregation in breast epithelial cells.Podoplanin - an emerging cancer biomarker and therapeutic target.Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients.
P2860
Q24536138-ADC72066-0A53-4F8F-99DB-D983453E4641Q26862087-D497E409-B934-4D63-90AD-A88CCB9753F5Q28393808-E9597D13-3C27-4CF0-AA85-05734D2C0AAFQ30032296-C42D1BD8-C4A1-4457-8266-E33E9B75172BQ30453962-6CBCBFBB-1E8B-43FE-90FE-CA911CA0E2A8Q33993282-CA32731E-A42D-4AAF-BE0E-E424F982F091Q34378792-4AF30768-D9A7-4490-A757-6D373C7944FDQ34585093-4A07008F-AFF1-40D8-A112-866B08A135E0Q34944550-EC47481B-2BA5-4600-9B7E-5AB94D04C329Q35051827-216922CA-E2BC-491C-828C-411D800E8DB4Q35603122-A6DE9627-CE0E-43F2-AD72-063D05F31463Q35829198-17CCC25A-5E54-4E64-952A-52298EC233C1Q36618989-9996CB44-9A09-45FF-B71A-792E81332713Q36619756-11234C70-486B-410A-AFAF-AD5588FEF07BQ36728170-63446B81-6E35-488D-86B1-F5210BFFF4EEQ36755018-F232CE60-8CEE-4C13-95FC-1834D3B20AB0Q36790748-1D9A967D-8A1E-4094-9AD2-94F1D4D4632AQ36884419-0F927C17-0244-449E-B441-06C0FE5C4027Q36981843-40ED13D6-A590-4117-AEF0-4064A890CD90Q37106979-108C14E2-F07C-4610-9A53-8FA4BB59C0D1Q37107200-A66D2CEF-1617-4B45-BE23-AABAA9122569Q37290200-314D79FC-F52E-4ADC-8647-FD5B1553FEC8Q37354085-5A7BA3DA-C54A-44E1-9994-EEAF056F4CB7Q37629662-D9A034AA-609A-40B6-930D-6BB0C60E4009Q38007880-764DFCB0-C58F-44D1-A0EB-C2A0F2709534Q38030018-E57E7BB6-7969-4F93-84DB-2DA6EA226197Q38541291-5A27D7C8-DB6D-4F54-A6DF-BFA544C2E77DQ39029060-CEBC7DAE-5630-45F4-BBF4-1BCFB14FA75AQ39774134-289C62DA-F80C-41A8-AD62-2B55D6A465FBQ39834562-3E4F067F-4CDF-4F07-8B24-42F3B609754EQ40065992-493EB29F-A890-494E-AE67-D3FAF1657738Q40256482-C538103B-8BEA-4EB5-80AC-C967D9678F96Q40320322-0F9CAF19-6A94-4503-B3DA-4774A825A537Q46186672-FA0B649C-5C0F-4854-AAF0-22A0F6DE3E72Q47103961-2365E342-197D-4213-982C-74E0292F37EEQ52724361-A16362DB-F8D2-4A2F-81A0-6DB07A639D65Q55098679-32EA91A8-5840-4288-A5FF-5B0A26CE887F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Platelets and metastasis revisited: a novel fatty link.
@ast
Platelets and metastasis revisited: a novel fatty link.
@en
type
label
Platelets and metastasis revisited: a novel fatty link.
@ast
Platelets and metastasis revisited: a novel fatty link.
@en
prefLabel
Platelets and metastasis revisited: a novel fatty link.
@ast
Platelets and metastasis revisited: a novel fatty link.
@en
P2860
P356
P1476
Platelets and metastasis revisited: a novel fatty link.
@en
P2093
Gaorav P Gupta
Joan Massagué
P2860
P304
P356
10.1172/JCI200423823
P407
P577
2004-12-01T00:00:00Z